Document:

exv10w28

Exhibit 10.28

STOCK
APPRECIATION RIGHTS AGREEMENT

PURSUANT TO THE

ACADIA HEALTHCARE COMPANY, INC. 2011 INCENTIVE COMPENSATION
PLAN

* * * * *

Participant:                                         

Grant Date:                                         

Base Price: $_____

Number of Shares subject to this SAR:                                         

* * * * *

     THIS STOCK APPRECIATION RIGHTS AGREEMENT (this “Agreement”), dated as of the Grant
Date specified above, is entered into by and between Acadia Healthcare Company, Inc., a corporation
organized in the State of Delaware (the “Company”), and the Participant specified above,
pursuant to the Acadia Healthcare Company, Inc. 2011 Incentive Compensation Plan, as in effect and
as amended from time to time (the “Plan”), which is administered by the Committee; and

     WHEREAS, it has been determined under the Plan that it would be in the best interests of the
Company to grant the Stock Appreciation Rights (“SAR”) provided for herein to the
Participant.

     NOW, THEREFORE, in consideration of the mutual covenants and promises hereinafter set forth
and for other good and valuable consideration, the parties hereto hereby mutually covenant and
agree as follows:

          1. Incorporation By Reference; Plan Document Receipt. This Agreement is subject in
all respects to the terms and provisions of the Plan (including, without limitation, any amendments
thereto adopted at any time and from time to time unless such amendments are expressly intended not
to apply to the Award provided hereunder), all of which terms and provisions are made a part of and
incorporated in this Agreement as if they were each expressly set forth herein. Any capitalized
term not defined in this Agreement shall have the same meaning as is ascribed thereto in the Plan.
The Participant hereby acknowledges receipt of a true copy of the Plan and that the Participant has
read the Plan carefully and fully understands its content. In the event of any conflict between
the terms of this Agreement and the terms of the Plan, the terms of the Plan shall control.

          2. Grant of SAR. The Company hereby grants to the Participant, as of the Grant Date,
a SAR on the number of shares specified above. The SAR represents the right, upon exercise, to
receive either cash or a number of shares of Common Stock, or a combination of cash and shares of
Common Stock, with a Fair Market Value on the date of exercise equal, in each case, to the product
of (i) the aggregate number of shares with respect to which this
SAR is exercised and (ii) the excess of (A) the Fair Market Value of a share of Common Stock as of
the date of exercise over (B) the SAR Base Price specified above. Except as otherwise provided by
the Plan, the Participant agrees and understands that nothing contained in this Agreement

 

 

provides,
or is intended to provide, the Participant with any protection against potential future dilution of
the Participant’s interest in the Company for any reason. The Participant shall have no rights as
a stockholder with respect to any shares of Common Stock covered by the SAR unless and until the
Participant has become the holder of record of such shares, and no adjustments shall be made for
dividends in cash or other property, distributions or other rights in respect of any such shares,
except as otherwise specifically provided for in the Plan or this Agreement.

          3. Vesting and Exercise.

          (a) Vesting. Subject to the provisions of Section 3(b) hereof, the SAR shall vest and
become exercisable as follows, provided that the Participant has not incurred a Termination prior
to each such vesting date:

	 	 	 
	Vesting Date	 	Number of Shares
	[•]
	 	[•]

There shall be no proportionate or partial vesting in the periods prior to each vesting date and
all vesting shall occur only on the appropriate vesting date, subject to the Participant’s
continued service with the Company or any of its Subsidiaries on each applicable vesting date.
Upon expiration of the SAR, the SAR shall be cancelled and no longer exercisable.

          (b) Committee Discretion to Accelerate Vesting. Notwithstanding the foregoing, the
Committee may, in its sole discretion, provide for accelerated vesting of the SAR at any time and
for any reason.

          (c) Expiration. Unless earlier terminated in accordance with the terms and provisions
of the Plan and/or this Agreement, all portions of the SAR (whether vested or not vested) shall
expire and shall no longer be exercisable after the expiration of ten (10) years from the Grant
Date.

          4. Termination. Subject to the terms of the Plan and this Agreement, the SAR, to the
extent vested at the time of the Participant’s Termination, shall remain exercisable as follows:

          (a) Termination due to Death or Disability. In the event of the Participant’s
Termination by reason of death or Disability, the vested portion of the SAR shall remain
exercisable until the earlier of (i) one (1) year from the date of such Termination, and (ii) the
expiration of the stated term of the SAR pursuant to Section 3(c) hereof; provided,
however, that in the case of a Termination due to Disability, if the Participant dies
within such one (1) year exercise period, any unexercised SAR held by the Participant shall
thereafter be exercisable by the legal representative of the Participant’s estate, to the extent to
which it was exercisable at the
time of death, for a period of one (1) year from the date of death, but in no event beyond the
expiration of the stated term of the SAR pursuant to Section 3(c) hereof.

          (b) Involuntary Termination Without Cause. In the event of the Participant’s
involuntary Termination by the Company without Cause, the vested portion of the SAR shall

2

 

remain
exercisable until the earlier of (i) ninety (90) days from the date of such Termination, and (ii)
the expiration of the stated term of the SAR pursuant to Section 3(c) hereof.

          (c) Voluntary Termination. In the event of the Participant’s voluntary Termination
(other than a voluntary Termination described in Section 4(d) hereof), the vested portion of the
SAR shall remain exercisable until the earlier of (i) thirty (30) days from the date of such
Termination, and (ii) the expiration of the stated term of the SAR pursuant to Section 3(c) hereof.

          (d) Termination for Cause. In the event of the Participant’s Termination for Cause or
in the event of the Participant’s voluntary Termination (as provided in Section 4(c) hereof) after
an event that would be grounds for a Termination for Cause, the Participant’s entire SAR (whether
or not vested) shall terminate and expire upon such Termination.

          (e) Treatment of Unvested SAR upon Termination. Any portion of the SAR that is not
vested as of the date of the Participant’s Termination for any reason shall terminate and expire as
of the date of such Termination.

          5. Method of Exercise. Subject to Section 8, to the extent that all or a portion of
the SAR has become vested and exercisable, such portion of the SAR may thereafter be exercised by
the Participant, in whole or in part, at any time or from time to time prior to the expiration of
the SAR as provided herein and in accordance with Sections 7.4(c) and 7.4(d) of the Plan,
including, without limitation, by the filing of any written form of exercise notice as may be
required by the Committee.

          6. Non-Transferability. The SAR, and any rights and interests with respect thereto,
issued under this Agreement and the Plan shall not be sold, exchanged, transferred, assigned or
otherwise disposed of in any way by the Participant (or any beneficiary(ies) of the Participant),
other than by testamentary disposition by the Participant or the laws of descent and distribution.
Any attempt to sell, exchange, transfer, assign, pledge, encumber or otherwise dispose of or
hypothecate in any way the SAR, or the levy of any execution, attachment or similar legal process
upon the SAR, contrary to the terms and provisions of this Agreement and/or the Plan shall be null
and void and without legal force or effect.

          7. Governing Law. All questions concerning the construction, validity and
interpretation of this Agreement shall be governed by, and construed in accordance with, the laws
of the State of Delaware, without regard to the choice of law principles thereof.

          8. Withholding of Tax. The Company shall have the power and the right to deduct or
withhold, or require the Participant to remit to the Company, an amount sufficient to satisfy any
federal, state, local and foreign taxes of any kind (including, but not limited to, the
Participant’s FICA and SDI obligations) which the Company, in its sole discretion, deems
necessary to be withheld or remitted to comply with the Code and/or any other applicable law,
rule or regulation with respect to the SAR and, if the Participant fails to do so, the Company may
otherwise refuse to issue or transfer any shares of Common Stock otherwise required to be issued
pursuant to this Agreement. Any statutorily required withholding obligation with regard to the

3

 

Participant may be satisfied by reducing the amount of cash or shares of Common Stock otherwise
deliverable upon exercise of the SAR.

          9. Entire Agreement; Amendment. This Agreement, together with the Plan, contains the
entire agreement between the parties hereto with respect to the subject matter contained herein,
and supersedes all prior agreements or prior understandings, whether written or oral, between the
parties relating to such subject matter. The Committee shall have the right, in its sole
discretion, to modify or amend this Agreement from time to time in accordance with and as provided
in the Plan. This Agreement may also be modified or amended by a writing signed by both the
Company and the Participant. The Company shall give written notice to the Participant of any such
modification or amendment of this Agreement as soon as practicable after the adoption thereof.

          10. Notices. Any notice hereunder by the Participant shall be given to the Company in
writing and such notice shall be deemed duly given only upon receipt thereof by the General Counsel
of the Company. Any notice hereunder by the Company shall be given to the Participant in writing
and such notice shall be deemed duly given only upon receipt thereof at such address as the
Participant may have on file with the Company.

          11. No Right to Employment. Any questions as to whether and when there has been a
Termination and the cause of such Termination shall be determined in the sole discretion of the
Committee. Nothing in this Agreement shall interfere with or limit in any way the right of the
Company, its Subsidiaries or its Affiliates to terminate the Participant’s employment or service at
any time, for any reason and with or without Cause.

          12. Transfer of Personal Data. The Participant authorizes, agrees and unambiguously
consents to the transmission by the Company (or any Subsidiary) of any personal data information
related to the SAR awarded under this Agreement for legitimate business purposes (including,
without limitation, the administration of the Plan). This authorization and consent is freely
given by the Participant.

          13. Compliance with Laws. The issuance of this SAR (and the shares of Common Stock
upon exercise of this SAR) pursuant to this Agreement shall be subject to, and shall comply with,
any applicable requirements of any foreign and U.S. federal and state securities laws, rules and
regulations (including, without limitation, the provisions of the Securities Act, the Exchange Act
and in each case any respective rules and regulations promulgated thereunder) and any other law or
regulation applicable thereto. The Company shall not be obligated to issue the SAR or any of the
shares pursuant to this Agreement if any such issuance would violate any such requirements.

          14. Section 409A. Notwithstanding anything herein or in the Plan to the contrary,
this SAR award is intended to be exempt from the applicable requirements of Section 409A of the
Code and shall be limited, construed and interpreted in accordance with such intent.

          15. Binding Agreement; Assignment. This Agreement shall inure to the benefit of, be
binding upon, and be enforceable by the Company and its successors and assigns.

4

 

The Participant
shall not assign (except in accordance with Section 6 hereof) any part of this Agreement without
the prior express written consent of the Company.

          16. Headings. The titles and headings of the various sections of this Agreement have
been inserted for convenience of reference only and shall not be deemed to be a part of this
Agreement.

          17. Counterparts. This Agreement may be executed in one or more counterparts, each of
which shall be deemed to be an original, but all of which shall constitute one and the same
instrument.

          18. Further Assurances. Each party hereto shall do and perform (or shall cause to be
done and performed) all such further acts and shall execute and deliver all such other agreements,
certificates, instruments and documents as either party hereto reasonably may request in order to
carry out the intent and accomplish the purposes of this Agreement and the Plan and the
consummation of the transactions contemplated thereunder.

          19. Severability. The invalidity or unenforceability of any provisions of this
Agreement in any jurisdiction shall not affect the validity, legality or enforceability of the
remainder of this Agreement in such jurisdiction or the validity, legality or enforceability of any
provision of this Agreement in any other jurisdiction, it being intended that all rights and
obligations of the parties hereunder shall be enforceable to the fullest extent permitted by law.

          20. Acquired Rights. The Participant acknowledges and agrees that: (a) the Company
may terminate or amend the Plan at any time; (b) the award of the SAR made under this Agreement is
completely independent of any other award or grant and is made at the sole discretion of the
Company; (c) no past grants or awards (including, without limitation, the SAR awarded hereunder)
give the Participant any right to any grants or awards in the future whatsoever; and (d) any
benefits granted under this Agreement are not part of the Participant’s ordinary salary, and shall
not be considered as part of such salary in the event of severance, redundancy or resignation.

[Remainder of Page Intentionally Left Blank]

5

 

     IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
written above.

	 	 	 	 	 
	 	ACADIA HEALTHCARE COMPANY, INC.

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 
	 	PARTICIPANT

 	 
	 	 	 
	 
	 	Name: 
	 
	 
	 	Social Security Number: 
	 

6Unassociated Document

Exhibit 10.1

Settlement Agreement

This Settlement Agreement dated September 16, 2011 (the “Agreement”) is, subject to Court approval, made and entered into by and among Brian Murphy (“Murphy”), on behalf of himself and derivatively on behalf of ‘mktg, inc.” (the “Plaintiff”), and Defendants Charles F. Tarzian, Fred Kaseff, Marc C. Particelli (“Particelli”), James H. Feeney, Herbert M. Gardner, John A. Ward III, UCC-mktg Investment, LLC (“UCC Investment”), UCC-mktg Partners, LLC, Charles Horsey (“Horsey”), Patty Hubbard, James Ferguson, Dave Arnold, and Nominal Defendant ‘mktg, inc.’ (“MKTG” or the “Company”) (collectively the “Defendants”) and Union Capital Corporation (“UCC”) (Plaintiff, Defendants and UCC collectively the “Parties,” and each a “Party”).

Whereas, on November 25, 2009, the Company entered into a Securities Purchase Agreement with UCC Investment, an investment vehicle organized by UCC, and certain of the Company’s directors and officers, providing for a $5 million financing led by UCC Investment (the “Financing”);

Whereas, on December 15, 2009, the Company closed the Financing and issued $2.5 million in aggregate principal amount of its Senior Secured Notes (“Secured Notes”), $2.5 million in aggregate stated value of its Series D Convertible Participating Preferred Stock (“Preferred Stock”) initially convertible into 5,319,149 shares of Common Stock, and Warrants to purchase 2,456,272 shares of its Common Stock;

Whereas, the Secured Notes issued in the Financing are secured by substantially all of the Company’s assets, currently bear interest at a rate of 16.5% per annum payable quarterly, and mature in one installment on December 15, 2012, and may be prepaid by the Company at any time;

 

  

  

  

 

Whereas, on December 15, 2009, in connection with the closing of the Financing, the Company entered into a management consulting agreement with UCC (the “Management Consulting Agreement”), pursuant to which UCC agreed to provide management advisory services to the Company and the Company agreed to pay to UCC an annual management fee (“Management Fee”) of $125,000 for such services;

Whereas, the members of the Company’s Board of Directors (the “Board”) as of the date of this Agreement are Elizabeth Black, Richard L. Feinstein, Gregory J. Garville (“Garville”), Arthur G. Murray (“Murray”), Horsey and Particelli;

Whereas, the Plaintiff filed an action against the Defendants entitled Brian Murphy, derivatively on behalf of ‘mktg, inc.’, v. Charles F. Tarzian, Fred Kaseff, Marc C. Particelli, James H. Feeney, Herbert M. Gardner, John A. Ward III, UCC-mktg Investment LLC, UCC-mktg Partners, LLC, Charles Horsey, Patty Hubbard, James Ferguson, and Dave Arnold, Defendants, and ‘mktg, inc.’, Nominal Defendant, Index No. 650364/2010, in the Supreme Court of the State of New York, County of New York (the “Action”); and

Whereas, the Plaintiff and Defendants, without admitting any liability one to the other, have reached an agreement regarding the settlement of all claims arising out of, in connection with, or relating in any way to the Action, including without limitation all matters that were or could have been asserted in the Action, and desire to dismiss the Action with prejudice; and

Whereas, in entering into this Agreement, none of the Parties concede the sufficiency or validity of any claims, cross claims, or defenses that were or could be asserted by any of the Parties in the Action.

 

  

2

  

 

Now Therefore, in consideration of the promises, releases, undertakings, and covenants set forth herein, the receipt and sufficiency of which is hereby acknowledged by the Parties, the Parties signatory hereto enter into this Agreement and agree as follows:

1.           Within two (2) business days of the execution of this Agreement by all Parties, the interest rate on the Secured Notes shall be reduced from 16.5 percentto 12.5 percent, such reduction to be effective from that point forward.

2.           MKTG covenants to the Plaintiff that within forty-five (45) calendar days of the Court’s execution and entry of an order approving this Agreement and dismissing the Action in its entirety, MKTG shall pay in full the amount due and owing on the Secured Notes, provided that, however, MKTG’s obligation to pay down the Secured Notes shall be delayed for an additional 45 calendar days, or for such other time period as MKTG and the Plaintiff shall reasonably and in good faith agree upon (but not beyond the existing maturity date of the Secured Notes), in the event that due to acts of God, governmental actions, or unusual volatility in the financial markets, compliance within the initial 45 day period is not reasonably possible. Nothing contained in this Section 2 shall be deemed to amend or modify the Secured Notes, it being understood that this covenant is between MKTG and the Plaintiff, and does not bind the holders of the Secured Notes.

3.           Within two (2) business days of the Court’s execution and entry of an order approving this Agreement and dismissing the Action in its entirety, UCC shall reduce its annual Management Fee under the Management Consulting Agreement by one-half from $125,000 to $62,500, such reduction to be effective from that point forward and on a pro-rated basis for the year in which the reduction takes effect. However, Garville and Murray, or any other directors that may in the future be designated in their stead by the holders of the Preferred Stock as a class, shall each be eligible to receive director’s fees in the same amounts received from time to time by the other non-employee directors of the Company.

 

  

3

  

 

4.           Particelli agrees that he shall not stand for re-election as director of the Company in the next election of the Company’s Board of Directors, provided that, notwithstanding any other provision of this Paragraph 4, Particelli may stand for re-election if Horsey, as a director of the Company, acting in his sole and absolute discretion, votes in favor of Particelli’s nomination for re-election or otherwise agrees in a writing delivered to the Board that Particelli should be permitted to stand for re-election. In connection with this Paragraph 4, Murphy acknowledges and agrees that any action or decision by Horsey regarding Particelli’s nomination for re-election, as set forth herein, is within Horsey’s sole and absolute discretion, and Murphy, both individually and derivatively on behalf of the Company, waives any right or ability to challenge any such action or decision by Horsey or to assert any claim based on or arising from any such action or decision by Horsey.

5.           Following the execution of this Agreement by all Parties, the Plaintiff shall file a request for attorney’s fees, incurred in this Action, with the Court. Subject to the Court’s approval, MKTG agrees to pay Plaintiff’s attorney’s fees up to $175,000, with one-half to be paid within five (5) business days of the Court’s execution and entry of an order granting Plaintiff’s request for attorney’s fees, and the remainder to be paid within sixty (60) calendar days after the first payment.

6.           Following the execution of this Agreement by all Parties and upon the Court’s approval of the form of notice set forth in Exhibit A attached hereto (the “Notice of Settlement”), in accordance with New York Business Corporation Law § 626(d) and at its own expense, MKTG shall use reasonable efforts to provide the notice to the Company’s stockholders of the proposed settlement of this Action by causing a copy of the Notice of Settlement to be sent by United States Postal Service commercial First-Class Mail to all owners of MKTG common stock as of the date of this Agreement, as shown in the stock records or register maintained by MKTG or the transfer agent for its common stock. To the extent requested by the Court, MKTG shall file with the Court proof of mailing of the Notice of Settlement as set forth in this Paragraph 6.

 

  

4

  

 

7.           The Parties hereby stipulate and agree that, upon the Court’s approval of this Agreement, the Action shall be dismissed with prejudice, and the Parties shall execute all documents necessary to dismiss the Action with prejudice, provided that the parties agree to request that the Action remain pending on the Court’s docket until MKTG makes payment of all attorney’s fees approved by the Court, as set forth in Paragraph 5 of this Agreement.

8.           In consideration for the foregoing, except for obligations under this Agreement, the Plaintiff, on behalf of himself and on behalf of his successors, heirs, assigns, and affiliates (collectively the “Releasors”), hereby irrevocably, unconditionally, fully, and completely releases, discharges, and acquits forever the Defendants and UCC and their agents, employees, representatives, predecessors, successors, affiliates, parent and subsidiary entities, corporate affiliates, joint ventures, assigns, shareholders, present and former officers and directors, attorneys, insurers, heirs, executors, and administrators (collectively, the “Releasees”) from any and all claims, counterclaims, actions, rights, causes of action, suits, debts, dues, offsets, sums of money, accounts, reckonings, bonds, bills, specialties, covenants, contracts, controversies, agreements, demands, liabilities, obligations, representations, and promises of actions of every kind and nature, variances, trespasses, damages and judgments whatsoever, whether known or unknown, suspected or unsuspected, fixed or contingent, existing or claimed to exist, both in law and equity, before any judicial or arbitral body anywhere in the world, that the Releasors ever had, now have, or may hereafter have against the Releasees for, upon, or by reason of any matter, cause of action, or thing whatsoever, from the beginning of the world to the date of execution of this Agreement, and further, the Plaintiff, derivatively on behalf of the Company and on behalf of its successors, heirs, assigns, and affiliates (collectively the “Derivative Releasors”), hereby irrevocably, unconditionally, fully, and completely releases, discharges, and acquits forever the Releasees from any and all claims, counterclaims, actions, rights, causes of action, suits, debts, dues, offsets, sums of money, accounts, reckonings, bonds, bills, specialties, covenants, contracts, controversies, agreements, demands, liabilities, obligations, representations, and promises of actions of every kind and nature, variances, trespasses, damages and judgments whatsoever, whether known or unknown, suspected or unsuspected, fixed or contingent, existing or claimed to exist, both in law and equity, before any judicial or arbitral body anywhere in the world, that the Derivative Releasors ever had, now have, or may hereafter have against the Releasees for, upon, or by reason of any matter, cause of action, or thing whatsoever, from the beginning of the world to the date of execution of this Agreement arising from or relating to the subject matter of the Action. Notwithstanding the foregoing, the Releasors do not waive any rights for indemnification by the Company held by virtue of Murphy’s position as a former director and officer of the Company, such rights being subject to the terms of that certain Separation Agreement by and between Murphy and CoActive Marketing Group, Inc., dated December 31, 2007, which agreement shall remain in full force and effect.

 

  

5

  

 

9.           Effective upon the entry of an Order by the Court dismissing the Action with prejudice, the Plaintiff waives any rights and hereby covenants not to initiate a lawsuit or administrative complaint or charge or commence any sort of action or proceeding whatsoever against Defendants or UCC or their current and former officers, agents, directors, employees and representatives, and their successors and assigns, at any time in the future based on any right or claim that arose on or before the effective date of this Agreement, and further, the Plaintiff, derivatively on behalf of the Company, waives any rights and hereby covenants not to initiate a lawsuit or administrative complaint or charge or commence any sort of action or proceeding whatsoever against Defendants or UCC or their current and former officers, agents, directors, employees and representatives, and their successors and assigns, at any time in the future based on any right or claim that arose on or before the effective date of this Agreement arising from or relating to the subject matter of the Action. The Plaintiff further covenants and agrees that he will not cause or encourage any other to initiate suit against Defendants or UCC or their current and former officers, agents, directors, employees and representatives, and their successors and assigns, at any time in the future based on any right or claim that arose on or before the effective date of this Agreement, and further represents that, from the date of the filing of the Amended Complaint in this Action to the date of this Agreement, he has not encouraged any other to initiate suit against Defendants or UCC or their current and former officers, agents, directors, employees and representatives, or their successors and assigns.

 

  

6

  

 

10.           The Plaintiff, on behalf of himself and derivatively on behalf of the Company, further expressly waives any and all rights he may have under any statute or common law principle that would limit the effect of the releases herein to those claims actually known or that Plaintiff should have known at the time of execution of this Agreement. In giving the releases herein, which includes claims which may be unknown to at present, Plaintiff acknowledges that he has read and understands Section 1542 of the Civil Code of the State of California which reads as follows:

“A general release does not extend to claims which the creditor does not know or suspect to exist in his or her favor at the time of executing the release, which if known by him or her must have materially affected his or her settlement with the debtor.”

The Plaintiff, on behalf of himself and derivatively on behalf of the Company, hereby expressly waives and relinquishes all rights and benefits under this section and any law or legal principle of similar effect in any jurisdiction with respect to claims released hereby.

11.           The Defendants and UCC hereby agree that they will not commence any action or proceeding, or assert any claims, against the Plaintiff based on the fact that Plaintiff commenced the Action against the Defendants.

 

  

7

  

 

12.           Neither this Agreement nor anything contained in it shall be deemed, construed, or treated in any respect as an admission by any Party hereto of any liability or wrongdoing.

13.           The Parties to this Agreement individually represent and warrant to each other that they have read and understand its terms, have the power and authority to execute it, have had and taken the opportunity to confer with legal counsel concerning its terms and all matters covered by and relating to it, and agree to be bound by its terms and conditions. The Parties have entered into this Agreement for reasons on their own and not based upon the representations of any Party hereto except as contained in the Agreement.

14.           The terms and provisions of this Agreement shall inure to the benefit of and be binding upon the Parties hereto and their respective heirs, legal representatives, successors, and assigns.

15.           This Agreement shall be interpreted, enforced, and governed by the substantive and procedural law of New York.

16.           This Agreement constitutes the entire agreement and understanding among the Parties with respect to the settlement of the Action, and supersedes any prior agreements, written or oral, with respect to such settlement. There are no other agreements, covenants, representations, or warranties respecting this Agreement or the other matters contemplated herein except as expressly set forth and provided herein. This Agreement cannot be changed, altered, amended, modified, terminated, or otherwise changed in any respect except by a writing duly executed by all authorized representatives of all the Parties, and the Parties acknowledge and agree that they will make no claim at any time or place that this Agreement has been orally altered or modified in any respect whatsoever.

17.           The representations, warranties, and covenants contained herein shall survive this Agreement.

  

8

  

18.           This Agreement may be executed in counterparts all of which together shall constitute one and the same instrument, and facsimile or pdf signatures shall be deemed the equivalent of original signatures.

19.           This Agreement is not effective until it has been fully executed by all Parties. The Parties understand that this Agreement remains subject to the Court’s approval. Subsequent to the execution of this Agreement by all Parties, the Plaintiff shall promptly submit to the Court a motion for approval of this Agreement and dismissal of the Action with prejudice. During the time that the Court’s approval of this Agreement is pending, the Parties shall not seek discovery in the Action or seek any form of relief other than relating to the terms of this Agreement.

20.           In the event this Agreement is not approved by the Court, this Agreement is voidable by the Parties, provided that this Agreement shall not be voidable by the Plaintiff in the event the Court declines the Plaintiff’s request for attorney’s fees or awards the Plaintiff attorney’s fees in a lesser amount than that specified in Paragraph 5 of this Agreement.

 

  

9

  

 

In Witness Whereof, the undersigned have executed this Agreement as of the date first above written.

 

	
Brian Murphy

	  	
‘mktg, inc.’

	 	 	 
	
/s/ Brian Murphy

	  	
By:

	
/s/ Charles Horsey

	  	  	  	
Title: CEO

	  	  	  	  	  
	
Charles F. Tarzian

	  	
Fred Kaseff

	 	 	 
	
/s/ Charles F. Tarzian

	  	
/s/ Fred Kaseff

	  	  	  	  	  
	
Marc C. Particelli

	  	
James H. Feeney

	 	 	 
	
/s/ Marc C. Particelli

	  	
/s/ James H. Feeney

	  	  	  	  	  
	
Herbert M. Gardner

	  	
John A. Ward III

	 	 	 
	
/s/ Herbert M. Gardner

	  	
/s/ John A. Ward, III

	  	  	  	  	  
	
UCC-mktg Investment, LLC

	  	
UCC-mktg Partners, LLC

	 	 	 
	
By:

	
/s/ Gregory J. Garville

	  	
By:

	
/s/ Gregory J. Garville

	
Title: Managing Director

	  	
Title: Managing Director

	  	  	  	  	  
	Charles Horsey	  	
Patty Hubbard

	 	 	 
	/s/ Charles Horsey	  	
/s/ Patty Hubbard

	  	  	  	  	  
	James Ferguson	  	
Dave Arnold

	 	 	 
	/s/ James Ferguson	  	
/s/ Dave Arnold

	  	  	  	  	  
	Union Capital Corporation	  	  	  
	 	 	 	 	 
	By:	
/s/ Gregory J. Garville

	  	  	  
	Title: President	  	  	  

  

10

  

 

EXHIBIT A

[Notice of Settlement]

  

11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00194-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00194-of-00352.parquet"}]]